Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
0 hedge funds and large institutions have $0 invested in Forward Pharma A/S American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $210K → $0 (-$210K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Mason Capital Management
New York
|
-$210K |
FWP Hedge Fund Activity: Q1 2024 in Review
0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2024, worth a combined $0 — down 100% from $210K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FWP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Mason Capital Management, exiting entirely with an estimated $210K sold.
- 0 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2024, down from 1 in Q4 2023.
- Funds reported $0 of Forward Pharma A/S American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2024 was Mason Capital Management, an estimated $210K sold.
Based on aggregated 13F filings for Q1 2024.